1 unchanged sentence
Rule 10b5-1 Trading Arrangements
−Removed: On February 26, 2025 , Andrew Serafin , Chief Strategy Officer of the Company, adopted a Rule 10b5-1 trading arrangement that is intended to satisfy the affirmative defense of Rule 10b5-1(c) for the sale of (i) up to 50,000 shares of the Company’s common stock related to the exercise of options, beginning on May 28, 2025 and continuing until May 31, 2026.
−Removed: On February 28, 2025 , Jeffrey Dierks , the former Chief Commercial Officer of the Company, adopted a Rule 10b5-1 trading arrangement that is intended to satisfy the affirmative defense of Rule 10b5-1(c) for the sale of (i) up to 48,765 shares of the Company’s common stock related to the exercise of options, and (ii) an indeterminable number of shares of the Company’s common stock that will depend on the number of shares sold to cover tax withholding obligations in connection with the vesting of 45,000 restricted stock units previously granted, beginning on July 1, 2025 and continuing until December 1, 2025.
−Removed: This plan was terminated on March 31, 2025 .
−Removed: On March 4, 2025 , Sandip Kapadia , Chief Financial Officer and Chief Administrative Officer of the Company, adopted a Rule 10b5-1 trading arrangement that is intended to satisfy the affirmative defense of Rule 10b5-1(c) for the sale of (i) up to 25,000 shares of the Company’s common stock related to the exercise of options, and (ii) up to 25,000 shares of the Company’s common stock related to the vesting of restricted stock units previously granted, beginning on July 1, 2025 and continuing until December 31, 2025.
+Added: During the three months ended June 30, 2025, no director or officer of the Company adopted or terminated a “ Rule 10b5-1 trading arrangement” or “non- Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K .
Incorporated by Reference
7 unchanged sentences
August 21, 2020
−Removed: Amendment No.
−Removed: 1 to License and Commercialization Agreement, dated July 31, 2022, by and between Bioprojet Société Civile de Recherche and Harmony Biosciences, LLC.
−Removed: April 30, 2024
−Removed: Amendment No.
−Removed: 2 to License and Commercialization Agreement, dated July 28, 2017, by and between Bioprojet Société Civile de Recherche and Harmony Biosciences, LLC.
−Removed: April 30, 2024
−Removed: Employment Letter between Harmony Biosciences, LLC, and Kumar Budur, as amended.
−Removed: Separation Agreement by and between Jeffrey Dierks, Harmony Biosciences Holdings, Inc., Harmony Biosciences, LLC, and Harmony Biosciences Management, Inc., dated March 20, 2025.
−Removed: March 24, 2025
Certification of Chief Executive Officer pursuant to Rules 13a-14(a) and 15d-14(a) of the Securities Exchange Act of 1934, as amended, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
4 unchanged sentences
Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
−Removed: The following financial statements from the Company ’ s Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2025, formatted in Inline XBRL:
+Added: The following financial statements from the Company ’ s Quarterly Report on Form 10-Q for the fiscal quarter ended June 30, 2025, formatted in Inline XBRL:
(i) Balance Sheets, (ii) Statements of Operations, (iii) Statements of Stockholders ’ Equity and (vi) Notes to Financial Statements, tagged as blocks of text and including detailed tags.
7 unchanged sentences
provided, however, that the Company may request confidential treatment pursuant to Rule 24b-2 of the Securities Exchange Act of 1934 for any schedules so furnished.
−Removed: Indicates management contract or compensatory plan or arrangement.
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
2 unchanged sentences
President, Chief Executive Officer and Director (principal executive officer)
+Added: August 5, 2025
/s/ Sandip Kapadia
1 unchanged sentence
Chief Financial Officer and Chief Administrative Officer (principal financial officer)
+Added: August 5, 2025
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.